3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Lymphoma, Large B-Cell, Diffuse
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Lobular
1
Interventions
Carboplatin
4
Trastuzumab
3
Cyclophosphamide
3
Paclitaxel
2
Letrozole
2
Fulvestrant
2
Docetaxel
2
repotrectinib
1
proto-oncogene protein c-fes-fps
1
palbociclib
1
neratinib
1
entrectinib
1
Vorinostat
1
Vinorelbine
1
Thiotepa
1
Taxes
1
Tamoxifen
1
Sugars
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Neoadjuvant Therapy
1
Naltrexone
1
Melphalan
1
Mastectomy, Segmental
1
Magnetic Resonance Spectroscopy
1
Liquid Biopsy
1
High-Energy Shock Waves
1
Goserelin
1
Fluorine-18
1
Epirubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Lobular
×
Drugs, Generic
×
Clear all
NCT03620643
2025-10-30
ROLo
Royal Marsden NHS Foundation Trust
Phase 2
Completed
33 enrolled
13 charts